Enanta Pharmaceuticals, Inc. Financial Ratios — ENTA Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Return on Common Equity (%)	- -	- -	- -	26.58	41.05	8.56	6.2	20.7	10.83	-7.88	-18.48	-33.79	-49.74	-67.17	-84.63
Return on Assets (%)	178.65	54.69	11.38	25.29	39.36	8.22	5.83	19.42	10.26	-7.41	-17.08	-29.91	-31.95	-27.67	-24.91
Return on Capital (%)	241.15	64.96	12.51	- -	40.99	8.55	6.19	20.67	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	230.47	64.63	11.7	- -	40.44	8.07	5.56	19.31	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	61.6	51.46	28.86	40.5	77.57	36.82	26.02	43.97	19.49	-31.02	-109.44	-140.29	-170.24	-176.47	-123.63
Operating Margin (%)	60.41	51.05	28.17	39.77	77.17	34.94	23.94	42.75	17.9	-34	-112.88	-143.74	-173.23	-179.92	-130.65
Incremental Operating Margin (%)	96.01	2,278.41	127.01	63.46	92.95	128.5	-42.81	61.37	3,612.75	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	55.66	51.31	30.03	40.36	77.98	36.89	26.21	45.07	22.2	-28.59	-110.82	-141.82	-165.39	-174.15	-127.9
Profit Margin (%)	55.66	51.31	30.03	72.14	49.1	24.55	17.23	34.82	22.6	-29.53	-81.38	-141.31	-168.95	-171.58	-125.36
Net Income to Common Margin (%)	55.66	51.31	30.03	72.14	49.1	24.55	17.23	34.82	22.6	-29.53	-81.38	-141.31	-168.95	-171.58	-125.36
Effective Tax Rate (%)	- -	- -	- -	- -	37.04	33.46	34.28	22.73	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	26.58	41.05	8.56	6.2	20.7	10.83	-7.88	-18.48	-33.79	-49.74	-67.17	-84.63

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Total Debt	- -	- -	- -	- -	1	1	- -	- -	- -	8	5	25	27	55	58
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	4	3	5	2	3
LT Debt	- -	- -	- -	- -	1	- -	- -	- -	- -	4	1	22	21	54	55
Total Debt/EBITDA	- -	- -	- -	- -	- -	0.02	0.02	- -	0.01	-0.21	-0.05	-0.21	-0.2	-0.46	-0.72
Net Debt/EBITDA	-0.27	-0.49	-0.96	-1.59	-0.17	-0.51	-2.46	-0.7	-1.28	2.29	0.54	0.36	0.63	0.31	0.4
Total Debt/EBIT	- -	- -	- -	- -	- -	0.02	0.02	- -	0.01	-0.19	-0.05	-0.2	-0.19	-0.46	-0.68
Net Debt/EBIT	-0.27	-0.49	-0.98	-1.62	-0.18	-0.54	-2.67	-0.72	-1.39	2.09	0.52	0.36	0.62	0.31	0.38
EBITDA to Interest Expense	8.16	- -	298.39	1,074.28	15,598.38	722.27	668.78	- -	- -	- -	- -	- -	-26.19	-10.91	-10.51
EBITDA-CapEx/Interest Expense	8.02	- -	278.84	1,017.17	15,306.38	616.98	606.12	- -	- -	- -	- -	- -	-27.95	-12.55	-12.19
EBIT to Interest Expense	8	- -	291.26	1,054.72	15,518.5	685.36	615.35	- -	- -	- -	- -	- -	-26.65	-11.12	-11.11
Interest Expense	3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5	11	8
Common Equity/Total Assets	-505.68	-221.14	94.44	95.65	95.99	95.97	92.36	95.04	94.42	93.72	91.03	85.6	46.88	34.2	23.05
Long-Term Debt/Equity (%)	- -	- -	- -	- -	0.22	0.17	0.13	0.07	0.04	0.84	0.28	6.96	9.8	41.88	84.61
Long-Term Debt/Capital (%)	- -	- -	- -	- -	0.22	0.17	0.13	0.07	0.04	0.83	0.28	6.45	8.73	29.27	44.66
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	0.22	0.16	0.12	0.07	0.04	0.79	0.26	5.96	4.59	14.32	19.51
Total Debt/Equity (%)	- -	- -	- -	- -	0.25	0.2	0.15	0.07	0.04	1.78	1.33	7.86	12.23	43.06	89.47
Total Debt/Capital (%)	- -	- -	- -	- -	0.25	0.2	0.15	0.07	0.04	1.75	1.32	7.29	10.9	30.1	47.22
Total Debt/Total Assets (%)	- -	- -	- -	- -	0.24	0.19	0.14	0.07	0.04	1.67	1.21	6.73	5.74	14.73	20.63
Net Debt to Equity	-31.14	-23.93	-8.02	-20.65	-9.2	-6.14	-21.77	-16.23	-11.08	-19.13	-14.32	-13.69	-39.4	-28.9	-49.91
Net Debt/Capital (%)	-45.23	-31.45	-8.72	-26.03	-10.1	-6.53	-27.77	-19.36	-12.45	-23.14	-16.46	-14.54	-54.09	-25.32	-35.76
EBITDA	26	21	9	19	125	33	27	91	40	-38	-106	-121	-135	-119	-81
EBITDA-CapEx	25	21	9	18	122	28	24	88	35	-39	-107	-123	-144	-137	-94
Operating Income (Loss)	25	21	9	19	124	31	25	88	37	-42	-110	-124	-137	-122	-85

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Cash Ratio	10.86	7.63	22.42	19.12	21.66	26.63	10.66	19.27	14.83	16.01	6.75	8.36	5.89	4.31	3.89
Current Ratio	11.68	8.25	23.14	22.75	25.45	29.43	11.33	23.74	17.77	18.08	8.82	10.45	6.73	5.21	4.21
Quick Ratio	10.98	8.15	22.77	20.07	24	28.26	11.17	23.46	17.1	17.52	8.43	10	6.52	4.99	4.03
CFO/Avg Current Liab	22.35	5.74	2.08	4.35	13.39	4.91	3.65	1.58	3.7	0.3	-2.32	-2.57	-2.23	-1.31	-0.36
Common Equity/Total Assets	-505.68	-221.14	94.44	95.65	95.99	95.97	92.36	95.04	94.42	93.72	91.03	85.6	46.88	34.2	23.05
Long-Term Debt/Equity (%)	- -	- -	- -	- -	0.22	0.17	0.13	0.07	0.04	0.84	0.28	6.96	9.8	41.88	84.61
Long-Term Debt/Capital (%)	- -	- -	- -	- -	0.22	0.17	0.13	0.07	0.04	0.83	0.28	6.45	8.73	29.27	44.66
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	0.22	0.16	0.12	0.07	0.04	0.79	0.26	5.96	4.59	14.32	19.51
Total Debt/Equity (%)	- -	- -	- -	- -	0.25	0.2	0.15	0.07	0.04	1.78	1.33	7.86	12.23	43.06	89.47
Total Debt/Capital (%)	- -	- -	- -	- -	0.25	0.2	0.15	0.07	0.04	1.75	1.32	7.29	10.9	30.1	47.22
Total Debt/Total Assets (%)	- -	- -	- -	- -	0.24	0.19	0.14	0.07	0.04	1.67	1.21	6.73	5.74	14.73	20.63
CFO/Total Liabilities	579.89	274.78	163.77	298.46	777.93	315.75	210.94	142.2	261.25	23.2	-177.83	-156.78	-42.01	-31.78	-8.92
CFO/CapEx	53.98	89.77	17.58	19.63	32.82	7.56	21.01	9.8	13.18	4.91	-93.33	-39.9	-11.39	-4.39	-1.49
Altman's Z-Score	-1.22	0.01	38.18	66.15	44.33	28.57	23.06	51.05	28.04	19.41	17.85	11.73	0.07	-0.78	-1.41

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Accounts Receivable Turnover	320.93	63.67	34.52	37.71	18.91	6.28	8.77	5.31	3.46	3.27	4.12	3.93	5.48	8.86	9.66
Days Sales Outstanding	1.14	5.73	10.57	9.68	19.3	58.16	41.63	68.73	105.41	111.47	88.49	92.97	66.66	41.18	37.79
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Market Capitalization	- -	- -	411	736	676	507	895	1,657	1,184	919	1,150	1,078	235	220	256
- Cash & Cash Equivalents	7	11	9	31	22	17	66	64	51	87	57	44	85	37	32
+ Preferred Equity and Hybrid Capital	154	159	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	1	1	- -	- -	- -	8	5	25	27	55	58
Enterprise Value	131	116	309	645	532	297	672	1,349	849	541	911	854	-108	27	125
Total Capital	22	44	110	149	237	270	302	394	463	464	405	347	243	184	123
Total Debt/Capital (%)	- -	- -	- -	- -	0.25	0.2	0.15	0.07	0.04	1.75	1.32	7.29	10.9	30.1	47.22
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.01	0.01	0.03	-0.25	2.07	0.46
EV/Sales	3.12	2.77	9.65	13.51	3.31	3.36	6.53	6.53	4.14	4.41	9.39	9.92	- -	0.4	1.91
EV/EBITDA	5.06	5.38	33.46	33.36	4.26	9.14	25.11	14.85	21.22	- -	- -	- -	- -	- -	- -
EV/EBIT	5.16	5.43	34.28	33.98	4.28	9.63	27.29	15.27	23.1	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	4.8	5.11	28.97	31.91	6.94	8.29	12.75	46.17	11.88	76.27	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	4.73	5.05	27.41	30.37	6.73	7.32	12.17	41.89	11.05	63.35	- -	- -	- -	- -	108.51
Diluted Market Cap	- -	- -	224	759	697	512	908	1,765	1,260	913	1,146	1,069	234	219	255
Diluted Enterprise Value	147	149	215	728	676	496	843	1,701	1,209	834	1,094	1,050	175	237	281
EV per Share	7.76	6.86	17.26	34.69	28.41	15.6	35.13	69.56	43.08	26.93	45.02	41.1	- -	1.27	5.85
TTM Sales	42	42	32	48	161	88	103	207	205	122	97	86	79	68	65
TTM EBITDA	26	21	9	19	125	33	27	91	40	-38	-106	-121	-135	-119	-81
TTM Operating Income	25	21	9	19	124	31	25	88	37	-42	-110	-124	-137	-122	-85
TTM Cash Flow to Firm	27	23	11	20	77	36	53	29	71	7	-70	-85	-98	-68	-12
TTM Free Cash Flow to Firm	28	23	11	21	79	41	55	32	77	9	-69	-83	-89	-50	1

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	09/30/2011	09/30/2012	09/30/2013	09/30/2014	09/30/2015	09/30/2016	09/30/2017	09/30/2018	09/30/2019	09/30/2020	09/30/2021	09/30/2022	09/30/2023	09/30/2024	09/30/2025

Price/Free Cash Flow	- -	- -	19.93	35.8	8.83	12.62	16.47	54.8	16.4	106.98	-16.55	-12.93	-2.49	-3.6	-40.06
EV/EBIT	5.16	5.43	34.28	33.98	4.28	9.63	27.29	15.27	23.1	- -	- -	- -	- -	- -	- -
Enterprise Value	131	116	309	645	532	297	672	1,349	849	541	911	854	-108	27	125
Low Price	- -	- -	14.31	18.31	30.13	16.75	22.17	44.52	58.02	38.4	40.32	37.59	11.03	8.08	4.09
EV/Sales	3.12	2.77	9.65	13.51	3.31	3.36	6.53	6.53	4.14	4.41	9.39	9.92	- -	0.4	1.91
EV/EBITDA	5.06	5.38	33.46	33.36	4.26	9.14	25.11	14.85	21.22	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	23.3	21.09	8.54	23.25	50.38	22.87	25.37	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	19.53	18.45	9.79	23.99	35.53	21.9	34.86	-29.71	-12.27	-10.85	-5.44	-2.24	-1.95
Price/Earnings High	- -	- -	26.83	24.75	12.43	36.49	50.6	34.19	45.09	-37.42	-15.12	-17.26	-9.72	-3.25	-4
Price/Earnings Low	- -	- -	14.55	9.76	7.12	14.63	23.87	11.91	24.5	-21.17	-10.3	-6.36	-1.73	-1.47	-1.07
Price/Book Value	- -	- -	3.72	4.95	2.86	1.88	2.97	4.21	2.56	2.02	2.88	3.36	1.09	1.7	3.96
Price/Book Value Average	- -	- -	3.12	4.33	3.28	1.94	2.09	4.03	3.52	2.37	2.43	4.15	3.37	2.02	2.47
Price/Book Value High	- -	- -	4.28	5.81	4.17	2.95	2.98	6.29	4.55	2.99	3	6.6	6.03	2.93	5.07
Price/Book Value Low	- -	- -	2.32	2.29	2.39	1.18	1.41	2.19	2.47	1.69	2.04	2.43	1.07	1.33	1.35
Price/Tangible Book Value	- -	- -	3.72	4.95	2.86	1.88	2.97	4.21	2.56	2.02	2.88	3.36	1.09	1.7	3.96
Price/Tangible Book Value Average	- -	- -	3.12	4.33	3.28	1.94	2.09	4.03	3.52	2.37	2.43	4.15	3.37	2.02	2.47
Price/Tangible Book Value High	- -	- -	4.28	5.81	4.17	2.95	2.98	6.29	4.55	2.99	3	6.6	6.03	2.93	5.07
Price/Tangible Book Value Low	- -	- -	2.32	2.29	2.39	1.18	1.41	2.19	2.47	1.69	2.04	2.43	1.07	1.33	1.35
Price/Sales	- -	- -	7	15.21	4.19	5.71	8.68	7.96	5.73	7.45	11.8	12.4	2.96	3.24	3.91
Price/Sales Average	- -	- -	5.87	13.31	4.81	5.89	6.12	7.63	7.88	8.77	9.98	15.34	9.19	3.84	2.44
Price/Sales High	- -	- -	8.06	17.86	6.1	8.96	8.72	11.91	10.19	11.05	12.31	24.39	16.43	5.57	5.01
Price/Sales Low	- -	- -	4.37	7.04	3.5	3.59	4.11	4.15	5.54	6.25	8.38	8.99	2.92	2.53	1.34
Price/Cash Flow	- -	- -	21.06	35.99	8.8	14.07	16.95	56.32	16.47	128.79	-16.37	-12.61	-2.27	-2.78	-13.25
Price/Cash Flow Average	- -	- -	17.65	31.48	10.09	14.51	11.95	53.94	22.64	151.59	-13.85	-15.58	-7.05	-3.3	-8.27
Price/Cash Flow High	- -	- -	24.25	42.24	12.81	22.08	17.02	84.2	29.29	190.96	-17.07	-24.79	-12.62	-4.78	-16.98
Price/Cash Flow Low	- -	- -	13.15	16.65	7.34	8.85	8.03	29.34	15.91	108.03	-11.62	-9.13	-2.24	-2.17	-4.53
Price/Free Cash Flow Average	- -	- -	16.7	31.31	10.12	13.02	11.61	52.49	22.53	125.92	-14	-15.99	-7.73	-4.27	-25.01
Price/Free Cash Flow High	- -	- -	22.94	42.01	12.84	19.8	16.54	81.94	29.15	158.62	-17.25	-25.42	-13.83	-6.19	-51.33
Price/Free Cash Flow Low	- -	- -	12.44	16.56	7.36	7.94	7.8	28.55	15.83	89.73	-11.75	-9.37	-2.46	-2.81	-13.69
EV/Sales Average	3.51	3.57	10.47	12.84	4.69	5.74	5.5	7.38	7.68	8.19	9.48	15.26	8.48	4.12	2.84
EV/Sales High	3.51	3.57	14.49	17.45	5.99	8.83	8.11	11.69	10.01	10.48	11.81	24.4	15.76	5.85	5.41
EV/Sales Low	3.51	3.57	7.73	6.49	3.37	3.43	3.49	3.87	5.32	5.65	7.87	8.85	2.19	2.8	1.73
EV/EBITDA Average	5.7	6.93	36.28	31.69	6.04	15.59	21.15	16.78	39.4	-26.39	-8.66	-10.88	-4.98	-2.33	-2.3
EV/EBITDA High	5.7	6.93	50.2	43.07	7.72	23.97	31.15	26.58	51.34	-33.79	-10.79	-17.39	-9.26	-3.31	-4.38
EV/EBITDA Low	5.7	6.93	26.78	16.02	4.35	9.32	13.41	8.8	27.31	-18.21	-7.19	-6.31	-1.29	-1.59	-1.4
EV/EBIT Average	5.81	6.99	37.17	32.28	6.07	16.42	22.99	17.25	42.89	-24.08	-8.4	-10.61	-4.9	-2.29	-2.17
EV/EBIT High	5.81	6.99	51.42	43.87	7.76	25.26	33.86	27.34	55.89	-30.83	-10.47	-16.97	-9.1	-3.25	-4.14
EV/EBIT Low	5.81	6.99	27.44	16.32	4.37	9.82	14.57	9.06	29.73	-16.62	-6.97	-6.16	-1.26	-1.56	-1.32
Last Price	- -	- -	22.92	39.57	36.14	26.61	46.8	85.46	60.08	45.78	56.81	51.87	11.17	10.36	11.97
High Price	- -	- -	26.39	46.44	52.58	41.77	47	127.77	106.8	67.88	59.23	102	62.06	17.8	15.34
Enterprise Value Average	147	149	336	613	754	507	566	1,524	1,576	1,003	920	1,315	672	278	185
Enterprise Value High	147	149	464	833	963	779	833	2,414	2,053	1,284	1,147	2,102	1,248	395	354
Enterprise Value Low	147	149	248	310	543	303	359	800	1,092	692	764	763	173	189	113

Shares Outstanding	17	17	18	19	19	19	19	19	20	20	20	21	21	21	21
Diluted Weighted Avg Shares	3	3	10	19	19	19	19	21	21	20	20	21	21	21	21
Basic Weighted Avg Shares	1	1	10	18	19	19	19	19	20	20	20	21	21	21	21
Revenue per Share	36.17	36.01	3.27	2.6	8.62	4.66	5.39	10.73	10.48	6.14	4.81	4.18	3.78	3.2	3.06
EBITDA per Share	22.28	18.53	0.95	1.05	6.68	1.72	1.4	4.72	2.04	-1.91	-5.27	-5.87	-6.43	-5.64	-3.79
Operating Income per Share	21.85	18.38	0.92	1.03	6.65	1.63	1.29	4.59	1.88	-2.09	-5.43	-6.01	-6.54	-5.75	-4
Basic EPS, GAAP	20.13	18.48	0.98	1.88	4.23	1.14	0.93	3.74	2.37	-1.81	-3.92	-5.91	-6.38	-5.48	-3.84
Basic EPS from Cont Ops	20.13	18.48	0.98	1.88	4.23	1.14	0.93	3.74	2.37	-1.81	-3.92	-5.91	-6.38	-5.48	-3.84
Diluted EPS, GAAP	8.84	8.11	0.98	1.8	4.09	1.13	0.91	3.48	2.21	-1.81	-3.92	-5.91	-6.38	-5.48	-3.84
Diluted EPS from Cont Ops	8.84	8.11	0.98	1.8	4.09	1.13	0.91	3.48	2.21	-1.81	-3.92	-5.91	-6.38	-5.48	-3.84
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	20.74	19.54	1.09	1.1	4.11	1.89	2.76	1.52	3.65	0.36	-3.47	-4.12	-4.92	-3.72	-0.9
Free Cash Flow per Basic Share	20.36	19.32	1.03	1.04	3.98	1.64	2.63	1.36	3.37	0.28	-3.51	-4.22	-5.35	-4.57	-1.51
Cash & Equivalents per Share	1.39	2.6	5.66	4.88	7.76	11.04	11.7	15.92	17.01	19.26	12.06	11.99	17.57	11.71	8.83
Book Value per Share	-7.84	-6.85	6.16	7.99	12.62	14.18	15.78	20.3	23.47	22.69	19.74	15.46	10.29	6.08	3.03
Tangible Book Value per Share	-7.84	-6.85	6.16	7.99	12.62	14.18	15.78	20.3	23.47	22.69	19.74	15.46	10.29	6.08	3.03

Enanta Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)